Home/Private label

Private-label partnership

Market our medical devices under your brand

VITROBIO offers partners medical devices based on formulations developed and evaluated by the laboratory. Your company markets them under its own brand, in the territories and on the terms agreed together.

Select an existing product

The starting point is an indication and a product in our range. Formulations are not created at a distributor’s request. For some indications, several options exist; their suitability and availability depend on your project, target markets and existing distribution agreements.

The medical device catalogue presents products and their indications. Projects still in development are identified separately: appearing on the website does not mean that they are available for commercialisation.

Identify responsibilities

VITROBIO remains the legal manufacturer. Its name and address appear on the packaging; your company is identified as the distributor. Our regulatory team works with yours to clarify the documentation and procedures relevant to the product and target country.

Our quality management system is certified to ISO 13485 by GMED. The FAQ explains the MDR status of marketed devices, separately from development projects. For your dossier, request the information applicable to the specific product rather than a general statement about an entire range. Read the partner FAQ.

Prepare your project

An initial brief helps focus the discussion:

  • Your company and distribution channels.
  • The countries where you intend to market the device.
  • The indication sought and the products of interest.
  • Known language and presentation requirements.
  • Forecast volumes and your desired launch period.

Minimum quantities, available capacity, lead times and packaging must be confirmed with the team. A catalogue listing alone does not establish project feasibility. The guide to planning a nasal spray project provides a detailed brief example.

Review the data and partnership terms

Indications, populations and precautions remain specific to each product. Available documentation and sharing arrangements are clarified during the discussion. To prepare your questions, read our article on assessing clinical data.

Any exclusivity relates to a defined formulation and territory; its duration and associated commitments are specified in the agreement. Marketing under your brand does not transfer manufacturing rights or rights to exploit the patents. These matters are discussed alongside the project’s commercial terms.

Talk to the laboratory

Tell us about your market and selected products. You can also identify points still to be clarified: indication, documentation, presentation or timing. The initial discussion aims to identify the options to examine and the next information needed.

Present your project to VITROBIO.